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HRV Response to Stressor
Placebo
Testosterone
Figure 2. Androgel 
application model. 
Figure 1. Experimental procedure timeline. Duration denotes ECG recording time. Bottom units are in minutes, with + denoting minutes after recording of baseline HR and HRV. Hearts denote periods where 
cardiovascular activity was recorded.
Figure 3. BioPac sensor placement. 
Used for in-lab physiological 
measures. 
Figure 5. Experimental results. Heart data recorded with BioPac MP150 and processed with Kubios HRV. Low state anxiety determined by STAI state score < 31. Low trait anxiety determined by STAI trait score < 
38. Error bars represent standard error with 95% CI. 
• Stress is a risk factor for cardiovascular disease, so it 
is important to understand the mechanisms that 
underlie cardiovascular responses to acute stress
• The steroid hormone testosterone is thought to play 
a key role in stress management
• Whether or not steroid hormone testosterone acts 
almost exclusively as enhancer1 or buffer2 of 
cardiovascular stress response is unknown
Research Questions
• Does testosterone indeed have an effect on 
cardiovascular responses to stress, and is this effect 
enhancing or acting as a buffer? 
• Does anxiety act as a psychological moderator on 
this proposed relationship?
Participants
N = 120 males (Mean age = 21.55  3.49 years, Range = 
18-39 years)
Protocol
• Testosterone. Topical administration of Androgel 
(containing testosterone/placebo), self-administered 
in morning 
• Stress. Trier Social Stress Test3 – Deliverance of speech 
& serial subtraction math task in front of 2 Judges 
(neutral affect) + video camera 
Measures
• Cardiovascular Activity. BioPac applied to participant 
to measure Heart Rate (HR) & High-frequency 
component of Heart Rate Variability (HRV) across 4 
epochs: Baseline, TSST-Prep, TSST-Speech + Math, 
TSST-Recovery 
• Anxiety. State-Trait Anxiety Inventory (STAI)4 – Self-
reported measures of anxiety
Analyses
• HR & HRV subjected to 4 (Epoch)  2 (T/P) Repeated 
Measures General Linear Model (GLM)
• State & Trait Anxiety Measures entered as continuous 
variable in 4  2  2 GLMs
• HR increased & HRV dropped during exposure to 
the stressor 
• Testosterone did not influence cardiovascular stress 
responses  
• When looking separately at individuals with high vs. 
low levels of state/trait anxiety, testosterone still do 
not impact cardiovascular stress responses
• Testosterone does not play a significant role in 
moderating HR or HRV changes during exposure to a 
stressor 
• Effects of testosterone on HRV were not moderated 
by individual levels of state or trait anxiety 
• Although testosterone does indeed play a role in the 
human stress response by influencing other factors 
(e.g. cortisol), there is no direct relation to the 
cardiovascular component of the stress reactivity
• Despite null results, obtained outcomes will help 
encourage future important questions surrounding 
steroid hormones and their interplay with stress and 
cardiovascular health 
Future Directions
• Gender5 & age6 differences to T/P response
• Investigation of other possible moderators, such as 
negative/positive affect7 & social status8
1. Hermans et al., Psychoneuroendocrinology, 32(8), 1052-1061, (2007). 
2. Stephens et al., Psychoneuroendocrinology, 66, 47-55, (2015).
3. Kirschbaum et al., Neuropsychobiology, 28(1-2), 76-81, (1993). 
4. Spielberger et al., Manual for the State-Trait Anxiety Inventory, (1983). 
5. Allen et al., Psychosomatic medicine, 55(6), 505-517, (1993). 
6. Kudielka et al., International Journal of Behavioral Medicine, 11(2), 116-121, (2004).
7. Steiner et al., Journal of Adolescent Health, 4, 14-21, (2002).
8. Josephs et al., Psychological Science, 14(2), 158-163, (2003). 
9. Frisch et al., Frontiers in Psychology, (2015), retrieved from 
http://journal.frontiersin.org/article/10.3389/fpsyg.2015.00014/full.








Time  HR: F(1.83,184.98) = 170.280, p < 0.001, η2 = 
0.628
Time  T/P: F(1.83,184.98) = 1.250, p = 0.287, η2 = 
0.012
Time  HR: F(2.79,282.32) = 19.127, p < 0.001, η2 = 
0.159
Time  T/P: F(2,200) = 0.997, p = 0.371, η2 = 0.01
Time  Trait: F(1.82,187.48) = 0.395, p = 0.655, η2 = 
0.004
Time  T/P  Trait: F(1.89,177.68) = 0.325, p = 0.711, 
η2 = 0.003
Time  State: F(1.85,187.08) = 2.805, p < 0.067, η2 = 
0.027
Time  T/P  State: F(1.90,180.92) = 0.189, p = 
0.818, η2 = 0.002
Time  T/P  State: F(2.94,279.32) = 0.195, p = 
0.896, η2 = 0.002
Time  T/P  Trait: F(2.68,251.90) = 0.272, p = 0.824, 
η2 = 0.003
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